glp-1 and cancer risk No Increased for Thyroid in Diabetic Patients Prescribed Medications Compared to Those Prescribed Insulin Use of Glucagon-Like Peptide-1 Receptor

Pricing strategy: The pharmaceutical companies that produce GLP-1 drugs for weight loss have chosen a pricing strategy that focuses on maximizing profit from a smaller patient population rather than pursuing a lower profit margin across a larger customer base

Acknowledgments Sushma Soni, CMPP, of inScience Communications, Springer Healthcare (Philadelphia, Pa.), and Amy Zannikos, PharmD, CMPP, on behalf of inScience Communications, Springer Healthcare, provided medical writing support, which was funded by AstraZeneca

GLP-1 receptors are present in areas of the brain tied to dopamine signalling and reward processing, which may help explain why some people report reduced interest in alcohol and other substances while taking GLP-1s

focused on GLP-1RAs and safety outcomes, including cholelithiasis

Whilst these medications offer significant benefits in glycaemic control and weight reduction, some patients report experiencing fatigue or tiredness during treatment

Autophagy in the liver: functions in health and disease